SYDNEY, AUSTRALIA: Singular Health Group (ASX: SHG) announced the official appointment of Mr Denning Chong as Managing Director and Chief Executive Officer.
Following his appointment as Interim CEO and Managing Director in April 2023, Mr Chong has been instrumental in leading a strategic review that has seen the consolidation of premises and streamlining of the Group’s structure to reduce operating costs, and a strong focus on enterprise-led sales of the 3Dicom software.
As a co-founder of Singular Health and previous Non-Executive Director of Singular Health, Mr Chong has a strong knowledge of the medical technology landscape, the Company’s operations and the support of the team and significant shareholders.
Singular Health’s Chairman, Howard Digby, said: “The Board is delighted to be confirming Denning’s appointment as CEO and Managing Director. Together with our team, Denning has moved very quickly to implement strong business development activities in our chosen markets and build a foundation for long term shareholder value. We wish Denning and the Singular team every success.”
Singular Health Group signs deal to acquire business of Global3D
Leave a Reply